Sunday, August 23, 2026
26.1 C
Bengaluru

Does Public-Private Partnership Benefit The Public?

Does This Public-Private Partnership Benefit The Public?” (Tuesday, July 8, 2025)

Many Indian states, following a Government of India initiative, have handed over public hospitals to private companies under Public-Private Partnership (PPP) models. These reforms aim to improve healthcare quality for low-income patients and reduce government expenditure. However, the article finds that in many cases, neither goal is reliably achieved.

Instead, PPPs risk increasing medical costs, creating access barriers for the poor, and potentially eroding the core principle of universal, free healthcare in government hospitals.

Key Points

✅ Rationale Behind PPPs
• Government hospitals often lack resources, staff, and infrastructure.
• PPPs aim to leverage private expertise and efficiency to improve services without increasing government spending.
• GOI set a target for 50% of hospital beds to be under PPPs.

✅ Concerns Highlighted
• Past PPP models have failed in several Indian states due to higher patient costs and reduced access for poor patients.
• Medical inflation in India (12–14%, highest in Asia) makes PPP healthcare risky for the poor.
• When private players take over public hospitals, free treatment can be replaced by insurance-based or fee-based models, leading to repeated costs for citizens who already funded hospitals via taxes.

✅ Numbers & Data
• Per capita expenditure on health in India remains low.
• Government expenditure on health in 2020-21 was ₹1,815 per person, while private expenditure was ₹4,025 per person, reflecting the burden on households.
• Private sector controls 62% of hospital beds but serves only 52% of hospitalised cases.
• PPP hospitals may prioritise profit over universal access.

✅ Impact on Medical Education
• PPP medical colleges charge high fees, reducing affordability and potentially affecting the supply of affordable doctors.

✅ Key Quote from the Article

“With medical inflation at 12–14% — the highest in Asia — India’s push for PPP healthcare could end up hurting those who can least afford it.”

✅ Broader Implication
• The article questions whether PPPs truly serve public interest or primarily benefit private entities, potentially undermining universal healthcare.

A MedicinManAI Feature

Hot this week

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.

With over 25 years of leadership experience across commercial...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Topics

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Sun Pharma: In the Eye of the Storm of Ophthalmologists

The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...

Does India Need to Reinvent the Wheel on Junk Foods?

In a written reply in the Lok Sabha in...
spot_img

Related Articles

spot_imgspot_img